AP NEWS

MJardin Group Commences Trading on OTCQX Best Market

January 15, 2019

DENVER--(BUSINESS WIRE)--Jan 15, 2019--MJardin Group, Inc. (“ MJardin ” or the “ Company ”) (CSE:MJAR) (OTCQX: MJARF), a global leader in cannabis management, announced today that its common stock has been approved to upgrade to the OTCQX Best Market, effective immediately.

OTCQX is considered by the U.S. Securities and Exchange Commission (SEC) as an “established public market” for the purpose of determining the public market price when registering securities for resale with the SEC. Ability to trade on OTCQX generally leads to improved market liquidity and broader public awareness.

“We are pleased to announce our upgrade to the OTCQX Best Market as we believe it will lead to improved liquidity, increased exposure to institutional and other accredited investors in the U.S., and a broadened shareholder base,” said Rishi Gautam, Chairman and Chief Executive Officer. “MJardin is well positioned and capitalized to execute on our global growth strategy as we continue to acquire, own and operate strategic cannabis assets across cultivation, processing and retail. We look forward to updating our shareholders on our continued progress and we are excited to increase the visibility and understanding of our unique business model and growth strategy among the U.S. investment community.”

About MJardin Group

MJardin is a global cannabis management platform with extensive experience in cultivation, processing, distribution and retail. For over 10 years, MJardin has refined cultivation methodologies, developed state of the art facilities and implemented vertical integration for and on behalf of license owners. As a well-capitalized organization, MJardin continues to pursue strategic expansion and M&A opportunities across global legal cannabis markets. MJardin is based in Denver, Colorado, with offices in Toronto, Canada and Barcelona, Spain. For more information, please visit www.mjardin.com.

The CSE has not in any way passed upon the merits of and has neither approved nor disapproved the contents of this news release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “ U.S. Securities Act ”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information

This news release contains forward-looking information based on current expectations. Statements about, among other things, future developments and the business and operations of MJardin, trading of MJardin’s shares on the OTCQX Best Market, the growth of or global footprint and our intentions to leverage our scale for continued organic growth and to pursue strategic investments are all forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such factors include, but are not limited to: our ability to identify and pursue growth, financing and other strategic objectives, and the regulatory and economic environments in the jurisdictions we operate or intend to operate or investment in. Although such statements are based on management’s reasonable assumptions at the date such statements are made, there can be no assurance that the proposed acquisition will occur and that such forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such forward-looking information. Accordingly, readers should not place undue reliance on the forward-looking information. MJardin assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190115005181/en/

CONTACT: Media:

Cory Ziskind

ICR

646-277-1232

cory.ziskind@icrinc.comInvestors:

Ali Mahdavi

Capital Markets & Investor Relations

416-962-3300

Ali.mahdavi@MJardin.com

or

Frank Knuettel II, 720-613-4019

Chief Strategy Officer

Frank.Knuettel@MJardin.com

KEYWORD: UNITED STATES NORTH AMERICA COLORADO

INDUSTRY KEYWORD: HEALTH ALTERNATIVE MEDICINE MEDICAL SUPPLIES GENERAL HEALTH

SOURCE: MJardin Group, Inc.

Copyright Business Wire 2019.

PUB: 01/15/2019 08:00 AM/DISC: 01/15/2019 08:01 AM

http://www.businesswire.com/news/home/20190115005181/en

AP RADIO
Update hourly